| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $26.3M | +10.1% |
| SG&A Expense | $24.3M | +57.6% |
| Operating Income | -$50.6M | +55.7% |
| Interest Expense | $577K | +17.5% |
| Income Tax | $0 | — |
| Net Income | -$49.2M | +57.1% |
| EPS (Basic) | -$1.30 | +63.9% |
| EPS (Diluted) | -$1.30 | +63.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.8M | -64.5% |
| Short-term Investments | $54.3M | — |
| Current Assets | $93.7M | -10.9% |
| Total Assets | $96.0M | -11.6% |
| Current Liabilities | $10.0M | +10.2% |
| Long-term Debt | $24.9M | +416.2% |
| Stockholders' Equity | $61.1M | -35.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$35.5M | -88.1% |
| Capital Expenditures | $45K | -82.1% |
| Investing Cash Flow | -$53.9M | -517.9% |
| Financing Cash Flow | $22.5M | -63.9% |
| Free Cash Flow | -$35.5M | -85.8% |